Lupus Nephritis : Frontiers and Challenges.

Intro -- LUPUS NEPHRITIS: FRONTIERS AND CHALLENGES -- LUPUS NEPHRITIS: FRONTIERS AND CHALLENGES -- LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA -- CONTENTS -- PREFACE -- Chapter 1: INTRODUCTION -- Chapter 2: IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS NEPHRITIS -- INTRODUCTION -- HISTORY AND ORIGIN OF ANTI-DNA ANTIBODIES -- PATHOGENICITY OF AUTOANTIBODIES -- NUCLEOSOMES -- APOPTOSIS -- REACTIVE NITROGEN AND OXYGEN SPECIES -- IMMUNE COMPLEX -- Chapter 3: BK VIRUS AND SYSTEMICLUPUS ERYTHEMATOSUS -- EXPERIMENTAL BASIS FOR ASSOCIATION BETWEEN BK VIRUS AND LUPUS -- CLINICAL STUDIES STUDYING THE ASSOCIATION BETWEEN BKV AND LUPUS -- Chapter 5: TREATMENT OF LUPUS NEPHRITIS -- INTRODUCTION -- Chapter 4: CLASSIFICATION OF LUPUS GLOMERULONEPHRITIS (LGN) -- INTRODUCTION -- HISTOLOGICAL CLASSIFICATION OF LUPUS NEPHRITIS LESIONS -- CLASSIFICATION OF LUPUS GLOMERULONEPHRITIS (LGN) -- CLASS I: (FIGURE 1) -- CLASS II (PURE MESANGIAL LESIONS): (FIGURE 2) -- DEFINITION OF ACTIVE AND CHRONIC GLOMERULAR LESIONS [62] -- CHRONIC LESIONS (FIGURE 11) -- CLASS III (FIGURE 12) -- CLASS IV (FIGURE 14, 15) -- CLINICOPATHOLOGICAL CORRELATIONS OF CLASS IV -- CLASS V (FIGURE 16) -- CLINICAL PICTURE OF CLASS V LUPUS NEPHRITIS -- (CLASS VI) ADVANCED SCLEROSING LUPUS NEPHRITIS -- ADDITIONAL PATHOLOGICAL FEATURES ASSOCIATED WITH SLE -- LUPUS NEPHRITIS ACTIVITYAND CHRONICITY INDICES [64, 75] -- WHAT IS THE VALUE OF RENAL BIOPSY IN A PATIENT WITH SLE? -- WHAT IS THE VALUE OF RE-BIOPSYAND WHEN IS IT INDICATED? -- DIAGNOSIS AND MONITORING OF RENAL DISEASE -- PROGNOSTIC FACTORS AND OUTCOME MEASURES -- Chapter 5: TREATMENT OF LUPUS NEPHRITIS -- INTRODUCTION -- TERMINOLOGY USED IN THE MANAGEMENT OF LUPUS NEPHRITIS [83] -- TARGETS OF TREATMENT STRATEGIES IN LN -- TREATMENT PARADIGM -- CORTICOSTEROIDS -- CYCLOPHOSPHAMIDE -- MYCOPHENOLATE MOFETIL (MMF) AND MYCOPHENOLATE SODIUM.

ERYTHROPOIETIN (EPO) -- INFECTION RISK AND VACCINATION -- IMMUNOTHERAPY -- PERIPHERAL BLOOD STEM CELL TRANSPLANTATION -- Chapter 6: END-STAGE RENAL DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS -- RENAL TRANSPLANTATION AND SYSTEMIC LUPUS ERYTHEMATOSUS -- RISK OF RECURRENCE -- IMMUNOSUPPRESSIVE THERAPY -- RESULTS OF RENAL TRANSPLANTATION -- RENAL TRANSPLANTATION AND SLE SUMMARY -- Chapter 7: LUPUS NEPHRITIS IN CHILDREN -- TREATMENT -- OUTCOME OF LN IN CHILDREN -- Chapter 8: LUPUS NEPHRITIS AND PREGNANCY -- INTRODUCTION -- LUPUS FLARE -- IMPACT OF LUPUS ON PREGNANCY -- IMPACT OF PREGNANCY ON LUPUS NEPHRITIS -- MANAGEMENT OF LUPUS NEPHRITIS DURING PREGNANCY -- Chapter 9: DRUG-INDUCED LUPUS ERYTHEMATOSUS AND LN -- SLE AND DILE -- ACKNOWLEDGEMENT -- REFERENCES -- INDEX -- Blank Page.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.